市北高新：公司未直接投资明视医疗、心迈医疗、瑞意旭联、瓴科医疗四家企业

Core Viewpoint - The company clarified its investment status in several medical technology firms, emphasizing that it does not have direct investments in these companies and that its indirect investments are minimal, thus not significantly impacting its financial performance [2] Group 1: Investment Details - The company has not directly invested in Ming Vision Medical, Xinmai Medical, Ruiyixulian, and Lingke Medical [2] - The company’s investment in Shanghai Delian Bojian Venture Capital Partnership (Limited Partnership) made investments in Lingke Medical Technology (Hangzhou) Co., Ltd. and Ming Vision Brain Machine Technology (Suzhou) Co., Ltd. in December 2025 [2] - The company does not participate in the daily management of the fund, indicating a limited operational role in these investments [2] Group 2: Impact on Financial Performance - The company stated that its investment share in the indirectly held companies is low, which will not have a significant impact on its operational performance [2] - Investors are advised to make rational investment decisions and be aware of investment risks [2]